LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.89
+0.10 (1.73%)
At close: Jul 2, 2026, 4:00 PM EDT
5.90
+0.01 (0.17%)
After-hours: Jul 2, 2026, 6:55 PM EDT
LENZ Therapeutics Stock Forecast
LENZ's stock price has decreased by -80.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, LENZ Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 443.29% higher than the current stock price, while the lowest is $12 (+103.74%) and the highest is $60 (+918.68%).
Price Target: $32 (+443.29%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 24, 2026 |
| Citi | Citi | Buy Reiterates $26 → $20 | Buy | Reiterates | $26 → $20 | +239.56% | May 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 → $31 | Buy | Maintains | $29 → $31 | +426.32% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $48 → $38 | Buy | Reiterates | $48 → $38 | +545.16% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Hold Downgrades $39 → $12 | Hold | Downgrades | $39 → $12 | +103.74% | May 12, 2026 |
Financial Forecast
Revenue This Year
19.03M
from 19.09M
Decreased by -0.29%
Revenue Next Year
64.52M
from 19.03M
Increased by 239.00%
EPS This Year
-4.56
from -2.85
EPS Next Year
-3.47
from -4.56
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.8M | ||
| Avg | 19.0M | ||
| Low | 12.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.2% | ||
| Avg | -0.3% | ||
| Low | -32.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.55 | ||
| Avg | -4.56 | ||
| Low | -5.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |